Cargando…

Anti-Oxidized LDL Antibodies and Coronary Artery Disease: A Systematic Review

Antibodies to oxidized LDL (oxLDL) may be associated with improved outcomes in cardiovascular disease. However, analysis is restricted by heterogenous study design and endpoints. Our objective was to conduct a comprehensive systematic review assessing anti-oxLDL antibodies in relation to coronary ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Berg, Victor J., Vroegindewey, Maxime M., Kardys, Isabella, Boersma, Eric, Haskard, Dorian, Hartley, Adam, Khamis, Ramzi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826549/ https://www.ncbi.nlm.nih.gov/pubmed/31618991 http://dx.doi.org/10.3390/antiox8100484

Ejemplares similares

Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
por: Khan, Tina Z., et al.
Publicado: (2021)

The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial
por: Hartley, Adam, et al.
Publicado: (2021)

Markers of Apoptosis Predict Cardiovascular Outcomes and Point to ‘Response to Injury’ as a Common Pathway Leading to Diabetes and Cardiovascular Events
por: Hartley, Adam, et al.
Publicado: (2018)

IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)
por: van den Berg, Victor J., et al.
Publicado: (2018)

Developing a Strategy for Interventional Molecular Imaging of Oxidized Low-Density Lipoprotein in Atherosclerosis
por: Pandey, Samata S., et al.
Publicado: (2017)

Depletion of Homeostatic Antibodies against Malondialdehyde-Modified Low-Density Lipoprotein Correlates with Adverse Events in Major Vascular Surgery
por: Hartley, Adam, et al.
Publicado: (2022)

Prognostic value of syntax score, intravascular ultrasound and near-infrared spectroscopy to identify low-risk patients with coronary artery disease 5-year results from the ATHEROREMO and IBIS-3 cohorts
por: Vlieger, Selina, et al.
Publicado: (2022)

A Novel Immunoassay for Malondialdehyde-Conjugated Low-Density Lipoprotein Measures Dynamic Changes in the Blood of Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Pandey, Samata S., et al.
Publicado: (2021)

Near Infrared Fluorescence (NIRF) Molecular Imaging of Oxidized LDL with an Autoantibody in Experimental Atherosclerosis
por: Khamis, Ramzi Y, et al.
Publicado: (2016)

Voice Biomarkers: The Most Modern and Least Invasive Tool for Coronary Assessment?
por: Hartley, Adam, et al.
Publicado: (2022)

SYNTAX score II predicts long-term mortality in patients with one- or two-vessel disease
por: Vroegindewey, Maxime M., et al.
Publicado: (2018)

Real-time handling of missing predictors
por: Boersma, Eric, et al.
Publicado: (2021)

The oxidation ratio of LDL: A Predictor for Coronary Artery Disease
por: Huang, Huiling, et al.
Publicado: (2008)

Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2014)

Dataset on blood biomarkers and GRACE score measured at admission for myocardial infarction in a large secondary hospital
por: van den Berg, Victor J., et al.
Publicado: (2018)

CAMs and Anti-CAMs. The Clinical Potential of Cell Adhesion Molecules
por: Keelan, Edward, et al.
Publicado: (1992)

IGF-1 is not related to long-term outcome in hyperglycemic acute coronary syndrome patients
por: Iswandi, Cindya P, et al.
Publicado: (2021)

Malondialdehyde-Modified LDL IgG Antibody Levels and Indices of Cardiac Function in Valvular Heart and Coronary Artery Disease Patients
por: Rahsepar, Amir Ali, et al.
Publicado: (2015)

Use of Lipid-Lowering Medications and the Likelihood of Achieving Optimal LDL-Cholesterol Goals in Coronary Artery Disease Patients
por: Karalis, Dean G., et al.
Publicado: (2012)

Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol
por: Sun, Xiao, et al.
Publicado: (2012)

Haptoglobin Genotype-Dependent Anti-Inflammatory Signaling in CD163(+) Macrophages
por: Landis, R. Clive, et al.
Publicado: (2013)

Small Dense LDL Level and LDL/HDL Distribution in Acute Coronary Syndrome Patients
por: Otrante, Alyann, et al.
Publicado: (2023)

Temporal Evolution of Serum Concentrations of High‐Sensitivity Cardiac Troponin During 1 Year After Acute Coronary Syndrome Admission
por: van den Berg, Victor J., et al.
Publicado: (2020)

Details on high frequency blood collection, data analysis, available material and patient characteristics in BIOMArCS
por: Boersma, Eric, et al.
Publicado: (2019)

Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites
por: Martin, Seth S., et al.
Publicado: (2009)

Interactions between leukocytes and endothelial cells in gout: lessons from a self-limiting inflammatory response
por: Haskard, Dorian O, et al.
Publicado: (2002)

Behçet’s Syndrome
por: Pickering, Matthew C, et al.
Publicado: (2000)

Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study
por: Kaura, Amit, et al.
Publicado: (2022)

Lifelong Reduction of LDL-Cholesterol Related to a Common Variant in the LDL-Receptor Gene Decreases the Risk of Coronary Artery Disease—A Mendelian Randomisation Study
por: Linsel-Nitschke, Patrick, et al.
Publicado: (2008)

High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial()
por: Khamis, Ramzi Y., et al.
Publicado: (2016)

Adiponectin in Relation to Coronary Plaque Characteristics on Radiofrequency Intravascular Ultrasound and Cardiovascular Outcome
por: Marino, Bárbara Campos Abreu, et al.
Publicado: (2018)

Microarray analysis of ox-LDL (oxidized low-density lipoprotein)-regulated genes in human coronary artery smooth muscle cells
por: Minta, Joe, et al.
Publicado: (2010)

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
por: Laaksonen, Reijo, et al.
Publicado: (2016)

Increased LDL susceptibility to oxidation accelerates future carotid artery atherosclerosis
por: Aoki, Toshinari, et al.
Publicado: (2012)

Association of Small Dense LDL Serum Levels and Circulating Monocyte Subsets in Stable Coronary Artery Disease
por: Krychtiuk, Konstantin A., et al.
Publicado: (2015)

Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol
por: Lee, Soo Youn, et al.
Publicado: (2016)

Platelet-Derived PCSK9 Is Associated with LDL Metabolism and Modulates Atherothrombotic Mechanisms in Coronary Artery Disease
por: Petersen-Uribe, Álvaro, et al.
Publicado: (2021)

Comparison of Estimated LDL Cholesterol Equations with Direct Measurement in Patients with Angiographically Confirmed Coronary Artery Disease
por: Shi, Boqun, et al.
Publicado: (2022)

White blood cell count combined with LDL cholesterol as a valuable biomarker for coronary artery disease
por: Liu, Zhiyun, et al.
Publicado: (2023)

Correction: Lifelong Reduction of LDL-Cholesterol Related to a Common Variant in the LDL-Receptor Gene Decreases the Risk of Coronary Artery Disease—A Mendelian Randomisation Study
por: Linsel-Nitschke, Patrick, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_48qm3elvjploq3odru5uhku429